Rosuvastatin in the chemoprevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in female rats

Acta Veterinaria

Volumn 61, Issue 5-6, 2011, Pages 445-460

  Kubatka, P ^a,b   Katarína, Žihlavniková ^a   Kajo, K ^a   Nadežda, Stollárová ^b   Pec M ^a,b   Bianka, Bojková ^c   Monika, Kassayová ^c   Orendas P ^c   Ahlers, I ^c  

^a University Teaching Hospital in Martin   (Slovakia)

^b Catholic University   (Slovakia)

^c P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Chemoprevention; Mammary carcinogenesis; Rat; Rosuvastatin

Indexed keywords

RATTUS;

EID: 84855861307     PISSN: 05678315     EISSN: 18207448     Source Type: Journal    
DOI: 10.2298/AVB1106445K     Document Type: Article

References (50)

1. Agarwal B, Bhendwal S, Halmos B, Moss SF, Ramey WG, Holt PR, 1999, Lovastatin Augments Apoptosis Induced by Chemotherapeutic Agents in Colon Cancer Cells, Clin Cancer Res, 5, 2223-9. (Pubitemid 29399281)
2. Blais L, Desgagne A, Le Lorier J, 2000, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study, Arch Intern Med, 160, 2363-8.
3. Cafforio P, Dammacco F, Gernone A, Silvestris F, 2005, Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells, Carcinogenesis, 26, 883-91. (Pubitemid 41214316)
4. Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E et al., 2006, Breast cancer growth prevention by statins, Cancer Res, 66, 8707-14. (Pubitemid 44449187)
5. Cauley JA, Zmuda JM, Lui LY, Hillier TA, Ness RB, Stone KL et al., 2003, Lipid-lowering drug use and breast cancer in older women: a prospective study, J Womens Health (Larchmt), 12, 749-56. (Pubitemid 37361917)
6. Crick DC, Andres DA, Danesi R, Macchia M, Waechter Ch J, 1998, Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells, J Neurochem, 70, 2397-405. (Pubitemid 28252365)
7. Demyanets S, Kaun C, Pfaffenberger S, Hohensinner PJ, Rega G, Pammer J et al., 2006, Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro, Biochem Pharmacol, 71, 1324-30.
8. Denoyelle C, Vasse M, Korner M, Mishal Z, Ganné F, Vannier JP et al., 2001, Cerivastatin, an inhibitor of HMGCoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study, Carcinogenesis, 22, 1139-48. (Pubitemid 32737327)
9. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA et al., 1998, Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study, JAMA, 279, 1615-22. (Pubitemid 28248586)
10. Duncan RE, El-Sohemy A, Archer MC, 2004, Mevalonate promotes the growth of tumors derived from human cancer cells in vivo and stimulates proliferation in vitro with enhanced cyclindependent kinase-2 activity, J Biol Chem, 279, 33079-84. (Pubitemid 39062951)
11. Duncan RE, El-Sohemy A, Archer MC, 2005, Statins and cancer development, Cancer Epidemiol Biomarkers Prev, 14, 1897-8. (Pubitemid 41161197)
12. Ghosh PM, Ghosh-Choudhury N, Moyer ML, Mott GE, Thomas CA, Foster BA, et al., 1999, Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line, Oncogene, 18, 4120-30. (Pubitemid 29363919)
13. Guijarro C, Blanco-Colio LM, Ortego M, Alonso C, Ortiz A, Plaza JJ, et al., 1998, 3-Hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture, Circ Res, 83, 490-500. (Pubitemid 28411050)
14. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D et al., 1999. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF, Science, 284, 1994-8. (Pubitemid 29309448)
15. Inano H, Suzuki K, Onoda M, Wakabayashi K, 1997, Anti-carcinogenic activity of simvastatin during the promotion phase of radiation-induced mammary tumorigenesis of rats, Carcinogenesis, 18, 1723-7. (Pubitemid 28134677)
16. Kato S, Smalley S, Sadarangani A, Chen-Lin K, Oliva B, Branes J et al., 2010, Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase, J Cell Mol Med, 14, 1180-93.
17. Katsiki N, Tziomalos K, Chatzizisis Y, Elisaf M, Hatzitolios AI, 2010, Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: Beneficial or detrimental? Atherosclerosis, 211, 9-14.
18. Katz MS, Minsky BD, Saltz LB, Riedel E, Chessin DB, Guillem JG, 2005, Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer, Int J Radiat Oncol Biol Phys, 62, 1363-70. (Pubitemid 40982056)
19. Kawata S, Yamasaki E, Nagase T, Inui Y, Ito N, Matsuda Y et al., 2001, Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial, Br J Cancer, 84, 886-91. (Pubitemid 32385829)
20. Kikuchi T, Nagata Y, Abe T, 1997, In vitro and in vivo antiproliferative effects of simvastatin, an HMG-CoA reductase inhibitor, on human glioma cells, J Neurooncol, 34, 233-9. (Pubitemid 27344573)
21. Koyuturk M, Ersoz M, Altiok N, 2004, Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase, Nerosci Lett, 370, 212-7. (Pubitemid 39370881)
22. Kubota T, Fujisaki K, Itoh Y, Yano T, Sendo T, Oishi R et al., 2004, Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors, Biochem Pharmacol, 67, 2175-86. (Pubitemid 38639926)
23. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ et al., 2000, The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals, Nat Med, 6, 1004-10.
24. Kusama T, Mukai M, Iwasaki T, Tatsuta M, Matsumoto Y, Akedo H et al., 2002, 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis, Gastroenterology, 122, 308-17. (Pubitemid 34116983)
25. Lubet RA, Boring D, Steele VE, Ruppert JM, Juliana MM, Grubbs CJ, 2009, Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis, Cancer Prev Res, 2, 161-7.
26. Macaulay RJ, Wang W, Dimitroulakos J, Becker LE, Yeger H, 1999, Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro, J Neurooncol, 42, 1-11. (Pubitemid 29216785)
27. Matar P, Rozados VR, Roggero EA, Scharovsky OG, 1998, Lovastatin inhibits tumor growth and metastasis development of a rat fibrosarcoma, Cancer Biother Radiopharm, 13, 387-93. (Pubitemid 29011312)
28. Mehta RG, 2000, Experimental basis for the prevention of breast cancer, Eur J Cancer, 36, 1275-82. (Pubitemid 30407015)
29. Minden MD, Dimitroulakos J, Nohynek D, Penn LZ, 2001, Lovastatin induced control of blast cell growth in an elderly patient with acute myeloblastic leukemia, Leuk Lymphoma, 40, 659-62. (Pubitemid 32303254)
30. Mueck AO, Seeger H, Wallwiener D, 2003, Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptornegative breast cancer cells, Menopause, 10, 332-6. (Pubitemid 36870505)
31. Narisawa T, Fukaura Y, Terada K, Umezawa A, Tanida N, Yazawa K et al., 1994, Prevention of 1,2-dimethylhydrazineinduced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice, Carcinogenesis, 15, 2045-8. (Pubitemid 24303058)
32. Narisawa T, Morotomi M, Fukaura Y, Hasebe M, Ito M, Aizawa R, 1996, Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats, Jpn J Cancer Res, 87, 798-804. (Pubitemid 26335806)
33. Negre-Aminou P, van Vliet AK, van Erck M, van Thiel GC, van Leeuwen RE, Cohen LH, 1997, Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors: comparison with other human cell types, Biochim Biophys Acta, 1345, 259-68. (Pubitemid 27171203)
34. Nubel T, Dippold W, Kleinert H, Kaina B, Fritz G, 2004, Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion, FASEB J, 18, 140-2.
35. Park C, Lee I, Kang WK, 2001, Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death, Carcinogenesis, 22, 1727-31. (Pubitemid 32952154)
36. Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS et al., 2005, Statins and the risk of colorectal cancer, N Engl J Med, 352, 2184-92. (Pubitemid 40727085)
37. PROSPER study group (Shepherd J et al.), 2002, Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial, Lancet, 360, 1623-30. (Pubitemid 35379733)
38. Rao S, Lowe M, Herliczek TW, Herliczek T, Lowe M, Keyomarsi K, 1998, Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of DK2 activity and redistribution of p21 and p27, independent of p53, Oncogene, 17, 2393-102.
39. Russo J, Russo IH, 2000, Atlas and histologic classification of tumors of the rat mammary gland, J Mammary Gland Biol Neoplasia, 5, 187-200. (Pubitemid 32045695)
40. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG et al., 1996, The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators, N Engl J Med, 335, 1001-09. (Pubitemid 26338729)
41. Scandinavian simvastatin survival study group (Pedersen TR, et al.), 1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S), Lancet, 344, 1383-9. (Pubitemid 24365311)
42. Seeger H, Wallwiener D, Mueck AO, 2003, Statins can inhibit proliferation of human breast cancer cells in vitro, Exp Clin Endocrinol Diabetes, 111, 47-8. (Pubitemid 36336817)
43. Shannon J, Tewoderos S, Garzotto M, Beer TM, Derenick R, Palma A, Farris PE, 2005, Statins and prostate cancer risk: a case-control study, Am J Epidemiol, 162, 318-25. (Pubitemid 41389713)
44. Stone BG, Evans CD, Prigge WF, Duane WC, Gebhard RL, 1989, Lovastatin treatment inhibits sterol synthesis and induces HMG-CoA reductase activity in mononuclear leukocytes of normal subjects, J Lipid Res, 30, 1943-52. (Pubitemid 20030373)
45. Tatsuta M, Iishi H, Baba M, Iseki K, Yano H, Uehara H et al., 1998, Suppression by pravastatin, an inhibitor of p21ras isoprenylation, of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats, Br J Cancer, 77, 581-7. (Pubitemid 28059465)
46. van de Donk NW, Kamphuis MM, Lokhorst HM, Bloem AC, 2002, The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells, Leukaemia (Baltimore), 16, 1362-71.
47. Vincent L, Chen W, Hong L, Mirshahi F, Mishal Z, Mirshahi-Khorassani T et al., 2001, Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect, FEBS Lett, 495, 159-66. (Pubitemid 32397697)
48. Waters D, Higginson L, Gladstone P, Kimball B, Le May M, Boccuzzi SJ et al., 1994, Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial, Circulation, 89, 959-68.
49. Weis M, Heeschen C, Glassford AJ, Cooke JP, 2002, Statins have biphasic effects on angiogenesis, Circulation, 105, 739-45. (Pubitemid 34157379)
50. Wong WW, Tan MM, Xia Z, Dimitroulakos J, Minden MD, Penn LZ, 2001, Cerivastatin triggers tumorspecific apoptosis with higher efficacy than lovastatin, Clin Cancer Res, 7, 2067-75. (Pubitemid 32994846)